TuesdayMay 16, 2023 10:30 am

FinovateSpring Focuses Quality Over Quantity, Bringing Together Top Fintech Executives and Unlocking Business Opportunities

For over a decade, FinovateSpring has attracted the best and brightest on and off the stage, including decision-makers from across the financial services spectrum, including banks, brokerages, card issuers, payment providers, investment companies, insurance providers, and everything in between. This year’s FinovateSpring event continues the tradition, but this time in a new venue – Marriot Marquis San Francisco. More than 50+ live demos are scheduled for FinovateSpring, spread across two days on May 23-25, 2023 – themed to include personal/retail, business, backend/enabling, and outside-a-box technology. These demos are hand-selected to showcase their services and solutions, not just pitch them, showing…

Continue Reading

TuesdayMay 16, 2023 9:45 am

Lift Toronto 2023 Cannabis Conference & Expo Promises to Energize, Inspire, Educate, and Motivate Audiences from Across the Cannabis Ecosystem

In October 2018, Canada became the first developed country to legalize recreational cannabis for adult use (https://ibn.fm/xofpU). Aimed at curbing the illicit trade of the drug and launching a new source of economic growth, this move is playing a significant role in the economy. For instance, Deloitte’s study, which considered the direct, indirect, and induced economic activities, estimated that the industry had contributed US$43.5 billion to Canada’s economy between legalization and 2021 (https://ibn.fm/QdHpz). And as the country counts down to the fifth anniversary this October, the figure is expected to be higher, making the upcoming Lift Toronto 2023 Cannabis Conference…

Continue Reading

TuesdayMay 16, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Kicks Off FDA IND Filing Process with Granted CRO Contract to California-Based InClin, Inc.

Lexaria just awarded InClin, Inc. the contract for CRO services, in a move that lines up with the company’s upcoming FDA-registered, U.S. Phase 1b IND hypertension study, HYPER-H23-1 InClin will manage the study in the form of clinical site evaluation and selection, project management, personnel, site training, and more Patient dosing is set to kick off as soon as possible once the expected FDA IND filing and review is completed, which Lexaria hopes will be done this summer HYPER-H23-1 will be Lexaria’s most ambitious study yet, and upon its completion, it will move the company closer to FDA approval of…

Continue Reading

MondayMay 15, 2023 3:29 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Q3 2023 Financial Results, Provides Business Update

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, today announced financial results for the third quarter of the fiscal year 2023, which ended March 31, 2023. “The third quarter of fiscal year 2023 was an important period for InMed, as we achieved several key milestones across our different business segments, including completing enrollment in our phase 2 clinical trial for epidermolysis bullosa, marking the first time cannabinol (‘CBN’) has completed a phase 2 clinical trial. We look forward to the data read out during 3Q and will then…

Continue Reading

MondayMay 15, 2023 3:12 pm

QualityStocksNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Lands $1.25M Contract with Rutgers University

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, today announced its receipt of a $1.25 million contract for its K1 Blue Light Towers and K1 E-Phones. The State University of New Jersey (“Rutgers”) signed purchase orders for a total of 145 devices. The announcement reads, “Rutgers stands among America’s highest-ranked, most diverse public research universities and is the oldest, largest and top-ranked public university in the New York/New Jersey metropolitan area. It has been using Knightscope’s emergency communication devices since 2022 and has been slowly expanding its footprint of the familiar blue…

Continue Reading

MondayMay 15, 2023 2:47 pm

QualityStocksNewsBreaks – Sharing Services Global Corporation (SHRG), Subsidiary Announce New Probiotic Dietary Supplement

Sharing Services Global (OTCQB: SHRG) and its wholly owned subsidiary, The Happy Co., have unveiled a new probiotic dietary supplement product: Probio8. The Happy Co. is a leading producer and distributor of nootropic, functional beverage products with a focus on health and wellness. Gluten-free, sugar-free and vegan, Probio8 is delivered in capsule form and contains eight different strains of beneficial probiotics, prebiotics and postbiotics. According to the announcement, the new potent formula, which includes updated packaging, is an enhancement offering compared to the company’s previous probiotic supplement. “The pursuit of exceptional health is central to everything we do here,” said Sharing Services…

Continue Reading

MondayMay 15, 2023 2:35 pm

QualityStocksNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) Reports on Q1 2023 Financial Results

Jupiter Wellness (NASDAQ: JUPW), a wellness company focused on hair metabolism and skin therapies, has release a report on its first-quarter revenues for the period ended March 31, 2023. The company reported revenues for the quarter totaled $1,121,676, compared to $721,629 in Q1 2022. Operating expenses for the quarter came in at $1,496,537, compared to $2,978,933 for the same period in 2022, and net losses totaled $1,308,174 for the three months, compared to $2,919,775 for the same period in 2022. “I am thrilled with our team's progress this quarter, demonstrating substantial revenue growth and a significant reduction in operating expenses,”…

Continue Reading

MondayMay 15, 2023 2:23 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Q1 2023 Results, Corporate Update

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced its financial results for the quarter ended March 31, 2023. In addition, the company provided a clinical update of its anti-cancer drug candidate currently in development for the treatment of primary and metastatic brain and CNS cancer. “Over the course of the first quarter, our team has continued its flawless operational execution of our potentially pivotal study witnessed by our recent enrollment update boasting 100 patients now dosed in this global clinical…

Continue Reading

MondayMay 15, 2023 2:05 pm

QualityStocksNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Reports on Business Update, EMM Testing and Installation

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has provided an update for stockholders on key components of its business. The update covered  factory activities in Mishawaka, Indiana, and Tunica, Mississippi, as well as developments in Mullen Advanced Energy Operations, Bollinger Motors commercial vehicles 4-6, Mullen commercial vehicles Class 1 and 3 and the Mullen FIVE EV crossover program. In part, the update noted that on March 30, 2023, the MGT Lease Company, a national fleet sales and leasing provider, received delivery of Mullen EV cargo vans; shortly thereafter, MGT placed a $15.8 million order for 250 all-electric commercial…

Continue Reading

MondayMay 15, 2023 1:40 pm

QualityStocksNewsBreaks – Data443 Risk Mitigation Inc. (ATDS) Announces Strategic Acquisition of Select Assets of Israel-Based Cyren Ltd.

Data443 (OTC: ATDS), a data security and privacy software company for “All Things Data Security,” today announced its entry into a definitive agreement to acquire select assets from Cyren Ltd. According to the announcement, the acquisition will expand Data443’s capabilities and product offerings, solidifying its position as a market leader in the data security and privacy industry. “Cyren is a leader in emerging and high-volume risk mitigation for some of the world’s largest name brand organizations we all use today,” said Jason Remillard, Data443’s CEO and founder. “This business has a tremendous track record, providing fast-breaking threat detection services and…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered